Cardiovascular Disease Risk Factor Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting cardiovascular disease risk factor clinical trials across 10 countries. Studies span Not Applicable. Top locations include Athens, Greece, Bogotá, Colombia, Bologna, BO, Italy. Updated daily from ClinicalTrials.gov.


Cardiovascular Disease Risk Factor Trials at a Glance

7 actively recruiting trials for cardiovascular disease risk factor are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Athens, Bogotá, and Bologna. Lead sponsors running cardiovascular disease risk factor studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, John Bauer, and Biogipuzkoa Health Research Institute.

Browse cardiovascular disease risk factor trials by phase

Treatments under study

About Cardiovascular Disease Risk Factor Clinical Trials

Looking for clinical trials for Cardiovascular Disease Risk Factor? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiovascular Disease Risk Factor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiovascular Disease Risk Factor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity

Obesity and OverweightWeight LossWeight Management+2 more
John Bauer50 enrolled1 locationNCT06967389
Recruiting

CARAMEL Observational Study

MenopauseCardiovascular (CV) RiskPerimenopause+3 more
Biogipuzkoa Health Research Institute3,000 enrolled6 locationsNCT07695376
Recruiting
Not Applicable

New Taipei City 888 Digital Medical AI Platform for Prevention and Care of the Three Highs and Cardio-Renal-Vascular Diseases

HypertensionCardiovascular Disease PreventionHyperlipidemia+5 more
New Taipei City Medical Association4,162 enrolled1 locationNCT07588256
Recruiting

Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.

Cardiovascular Disease PreventionCoronary Artery Disease (CAD)Cardiovascular Diseases (CVD)+1 more
University College Dublin100 enrolled1 locationNCT07401550
Recruiting
Not Applicable

THE EFFECT OF ENDODONTIC TREATMENT ON CARDIOVASCULAR RISK BIOMARKERS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

Cardiovascular Disease Risk FactorPeriapical Periodontitis
Postgraduate Institute of Dental Sciences Rohtak80 enrolled1 locationNCT07343804
Recruiting
Not Applicable

Determining the Benefits of Exercise on Cardiovascular Risk in PTSD

Cardiovascular DiseasePTSDCardiovascular Disease Risk Factors
Massachusetts General Hospital10 enrolled1 locationNCT07260032
Recruiting

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

Cardiovascular (CV) RiskCardiovascular Disease PreventionCardiovascular Disease (CVD)+4 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna500 enrolled1 locationNCT07187947